Verona Pharma plc Update On Agm Procedure
08 April 2020 - 4:00PM
UK Regulatory
TIDMVRP
LONDON, April 08, 2020 (GLOBE NEWSWIRE) -- Verona Pharma plc (AIM: VRP)
(Nasdaq: VRNA) ("Verona Pharma" or the "Company"), a clinical-stage
biopharmaceutical company focused on developing and commercializing
innovative therapies for respiratory diseases, provides an update on its
upcoming Annual General Meeting ("AGM"), scheduled to be held at the
offices of Shakespeare Martineau at 60 Gracechurch Street, London EC3V
0HR, United Kingdom at 10.30 a.m. on April 16, 2020.
The Company currently plans to hold its AGM as scheduled, however given
the UK Government's present restrictions on public gatherings of more
than two people, the Board requests shareholders to vote by proxy rather
than attend the AGM in person. Any shareholders seeking to attend the
AGM in person will be refused entry.
By way of reminder, the deadline for delivery of completed proxy forms
by holders of the Company's ordinary shares is 10.30 a.m. on April 14,
2020. The equivalent deadline for proxy voting by holders of the
Company's American Depository Shares is 10 a.m. on April 9, 2020.
Verona Pharma continues to review the UK Government's restrictions and
recommends that shareholders monitor the Company's website and
announcements for any updates in relation to the AGM. In the event that
its AGM arrangements have to change, the Company will issue a further
communication via a regulatory information service.
A copy of our
https://www.globenewswire.com/Tracker?data=8Pw5dDrrYyta7egTU1c8Q0pGi-28v5Fn0lNHPqfZLvGl1jvks4H_ksJ7KdtPGyQn-2de_teBBtPSAGCBrgj9jGWzMWzLsQb9uqbdJcEhBw0uGtQgVcoB4P0dN9VM84cTxTuCVusVL2uDuLBSqIRblQUiW5T5r-79fAFZ754xxf9drRQVq9150B0gQ2fBmDCAtflsnCfkNNto5IHSztzFxH0wDNOrupr9MZl4loCLRM4=
AGM Notice and
https://www.globenewswire.com/Tracker?data=IYfS9qEzVhJSElJbcrFnP-UHTdCSZdhK8icpCnluDUcE1UilYF7zlClhsK_7tijJD-J_TJ8UEzmtDcm7E8JUITGmQoRlqQAbzZO1bebVYiDJAQIPJcvcTIRGlObmYjYhbnaEWgXapMErl5kLk3dFPWod9MtUfVaFAkUDW3aKwjQihyfIEdE8G3iQENHYHN8xe5DeSQPfHaYjcb0yMw5NknPZYuk8FiqgSJsigX3gCCk=
Annual Report are available on the Company's website within the
Investors section, www.veronapharma.com.
For further information, please contact:
Verona Pharma plc Tel: +44 (0)20 3283 4200
-------------------------------------------- ------------------------
Victoria Stewart, Director of Communications info@veronapharma.com
-------------------------------------------- ------------------------
N+1 Singer Tel: +44 (0)20 3283 4200
-------------------------------------------- ------------------------
(Nominated Adviser and UK Broker)
Aubrey Powell / George Tzimas / Iqra
Amin (Corporate Finance)
Tom Salvesen (Corporate Broking)
-------------------------------------------- ------------------------
(END) Dow Jones Newswires
April 08, 2020 02:00 ET (06:00 GMT)
Copyright (c) 2020 Dow Jones & Company, Inc.
Verona Pharma (LSE:VRP)
Historical Stock Chart
From Apr 2024 to May 2024
Verona Pharma (LSE:VRP)
Historical Stock Chart
From May 2023 to May 2024
Real-Time news about Verona Pharma Plc (London Stock Exchange): 0 recent articles
More Verona Pharma Plc News Articles